Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA processing refers to the series of molecular events that convert a primary RNA transcript (pre-RNA) into a mature, functional RNA molecule. This process is essential in eukaryotic cells and involves several modifications that prepare messenger RNAs (mRNAs), ribosomal RNAs (rRNAs), and transfer RNAs (tRNAs) for their respective roles in protein synthesis and other cellular functions. Key steps include capping, splicing, and polyadenylation for mRNA, as well as cleavage, methylation, and base modifications for rRNA and tRNA. RNA processing is a targetable process for therapeutic intervention.
Modulation of gene expression post-transcriptionally by targeting specific steps or factors involved in RNA processing. Mechanisms vary depending on the specific drug type (e.g., ASOs binding to target RNA, siRNAs inducing RNA degradation, small molecules inhibiting RNA processing enzymes).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Processing (None).